Insys Therapeutics Inc (INSY)-Financial and Strategic SWOT Analysis Review

Insys Therapeutics Inc (INSY)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH123460FSA
  • |
  • Pages: 50
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Insys Therapeutics Inc (INSY)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems to improve the quality of life for patients. The company has one marketed product, namely, Subsys, a sublingual fentanyl spray for breakthrough cancer pain (BTCP) in opioid-tolerant patients; and one product awaiting approval by the US FDA, Syndros (dronabinol oral solution) for the treatment of chemotherapy-induced nausea and vomiting (CINV) and anorexia associated with weight loss in patients with AIDS. Insys uses its proprietary sublingual spray technology to develop its products. The company offers its products to oncologists, pain specialists and supportive care centers. It has operations in the US and offers its products through third party agreements in international markets. Insys is headquartered in Chandler, Arizona, the US.

Insys Therapeutics Inc Key Recent Developments

Apr 24,2017: Dr. Steven James Joins Insys Therapeutics as Vice President of Medical Affairs

Apr 03,2017: Insys Therapeutics Reports Fourth Quarter and Year End 2016 Results

Mar 27,2017: Insys Announces Saeed Motahari to Become President and Chief Executive Officer and Member of the Board of Directors Effective April 17, 2017

Jan 09,2017: Insys Therapeutics Announces Retirement of Dr. John N. Kapoor as CEO and Chairman; Appoints Dr. Santosh Vetticaden as Interim CEO and Steven Meyer as Chairman of the Board

Nov 03,2016: Insys Therapeutics Reports Third Quarter 2016 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Insys Therapeutics Inc-Key Facts 6

Insys Therapeutics Inc-Key Employees 7

Insys Therapeutics Inc-Key Employee Biographies 8

Insys Therapeutics Inc-Major Products and Services 9

Insys Therapeutics Inc-Pharmaceutical Pipeline Products Data 10

Insys Therapeutics Inc, Pipeline Products by Therapy Area 10

Insys Therapeutics Inc, Pipeline Products by Development Phase 11

Insys Therapeutics Inc-History 12

Insys Therapeutics Inc-Company Statement 13

Insys Therapeutics Inc-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Section 2-Company Analysis 17

Insys Therapeutics Inc-Business Description 17

Insys Therapeutics Inc-Corporate Strategy 18

Insys Therapeutics Inc-SWOT Analysis 19

SWOT Analysis-Overview 19

Insys Therapeutics Inc-Strengths 19

Insys Therapeutics Inc-Weaknesses 20

Insys Therapeutics Inc-Opportunities 21

Insys Therapeutics Inc-Threats 22

Insys Therapeutics Inc-Key Competitors 23

Section 3-Company Financial Ratios 24

Financial Ratios-Capital Market Ratios 24

Financial Ratios-Annual Ratios 25

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Section 4-Company's Lifesciences Financial Deals and Alliances 31

Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32

Insys Therapeutics Inc, Recent Deals Summary 33

Section 5-Company's Recent Developments 34

Apr 24, 2017: Dr. Steven James Joins Insys Therapeutics as Vice President of Medical Affairs 34

Apr 03, 2017: Insys Therapeutics Reports Fourth Quarter and Year End 2016 Results 35

Mar 27, 2017: Insys Announces Saeed Motahari to Become President and Chief Executive Officer and Member of the Board of Directors Effective April 17, 2017 37

Jan 09, 2017: Insys Therapeutics Announces Retirement of Dr. John N. Kapoor as CEO and Chairman; Appoints Dr. Santosh Vetticaden as Interim CEO and Steven Meyer as Chairman of the Board 38

Nov 03, 2016: Insys Therapeutics Reports Third Quarter 2016 Results 39

Sep 21, 2016: Insys Therapeutics Announces CEO Succession Plan 40

Aug 03, 2016: Insys Therapeutics Reports Second Quarter 2016 Results 41

Apr 28, 2016: Insys Therapeutics Reports First Quarter 2016 Results 42

Feb 23, 2016: Insys Therapeutics Reports Fourth Quarter and Year End 2015 Results 43

Jan 25, 2016: Insys Therapeutics Releases Statement on Its Patient Services Center 45

Section 6-Appendix 46

Methodology 46

Ratio Definitions 46

About GlobalData 50

Contact Us 50

Disclaimer 50

List of Figures

Insys Therapeutics Inc, Pipeline Products by Therapy Area 10

Insys Therapeutics Inc, Pipeline Products by Development Phase 11

Insys Therapeutics Inc, Performance Chart (2012-2016) 28

Insys Therapeutics Inc, Ratio Charts 30

Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 32

List of Tables

Insys Therapeutics Inc, Key Facts 6

Insys Therapeutics Inc, Key Employees 7

Insys Therapeutics Inc, Key Employee Biographies 8

Insys Therapeutics Inc, Major Products and Services 9

Insys Therapeutics Inc, Number of Pipeline Products by Therapy Area 10

Insys Therapeutics Inc, Number of Pipeline Products by Development Stage 11

Insys Therapeutics Inc, History 12

Insys Therapeutics Inc, Other Locations 16

Insys Therapeutics Inc, Subsidiaries 16

Insys Therapeutics Inc, Key Competitors 23

Insys Therapeutics Inc, Ratios based on current share price 24

Insys Therapeutics Inc, Annual Ratios 25

Insys Therapeutics Inc, Annual Ratios (Cont...1) 26

Insys Therapeutics Inc, Annual Ratios (Cont...2) 27

Insys Therapeutics Inc, Interim Ratios 29

Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 31

Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 32

Insys Therapeutics Inc, Recent Deals Summary 33

Currency Codes 46

Capital Market Ratios 46

Equity Ratios 47

Profitability Ratios 47

Cost Ratios 48

Liquidity Ratios 48

Leverage Ratios 49

Efficiency Ratios 49

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Teva Pharmaceutical Industries Ltd Par Pharmaceutical Holdings Inc Mallinckrodt LLC Galena Biopharma Inc Depomed Inc BioDelivery Sciences International Inc

Insys Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8095
Site License
USD 250 INR 16190
Corporate User License
USD 375 INR 24285

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com